Standout Papers

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, e... 1998 2026 2007 2016 1.6k
  1. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy (1999)
    Diana Finzi, Joel N. Blankson et al. Nature Medicine
  2. HIV-Protease Inhibitors (1998)
    Charles Flexner New England Journal of Medicine
  3. Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications (2022)
    Catia Marzolini, Daniel R. Kuritzkes et al. Clinical Pharmacology & Therapeutics

Immediate Impact

16 by Nobel laureates 32 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
2019 Standout
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
2019 Standout
2 intermediate papers

Works of Charles Flexner being referenced

The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries
2018
Drug Development Strategies for Salvage Therapy: Conflicts and Solutions
2006
and 1 more

Author Peers

Author Last Decade Papers Cites
Charles Flexner 5567 5219 2322 178 10.4k
Willy Rozenbaum 4905 5786 3084 167 10.8k
Richard T. Davey 6119 6197 3156 170 11.6k
Samuel Broder 5741 5040 2808 120 12.2k
Richard B. Pollard 3611 3643 3724 264 10.3k
William T. Shearer 5515 2919 3523 317 12.9k
Angela D. M. Kashuba 6519 4768 2798 312 10.9k
Katherine Luzuriaga 6274 2925 2046 116 9.8k
S. Mallal 4721 4267 2388 290 14.1k
Gregory K. Robbins 4121 4230 2944 141 9.7k
Donna Mildvan 5293 3684 3845 128 9.4k

All Works

Loading papers...

Rankless by CCL
2026